# Single Ascending Doses of BIIB063 in Healthy Volunteers

> **NCT02555085** · PHASE1 · TERMINATED · sponsor: **Biogen** · enrollment: 29 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** BIIB063
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02555085
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09-30
- **Primary completion:** 2016-06-01
- **Final completion:** 2016-06-01
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Clinical study terminated due to preclinical safety findings in non-human primates.
- **Last updated:** 2017-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02555085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02555085, "Single Ascending Doses of BIIB063 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02555085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*